Product Information
CLARITHROMYCIN ER 500 MG TAB is a generic product labeled by Lannett Company Inc., priced at $1.9182 per EA under NDC 00527193006. Its NADAC has been published 379 times since Apr 3, 2019.
FDA first approved this application on Jul 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Lannett Company Inc.NDC
00527193006
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA208987FDA Approved
7/9/2018
TE Code
AB
On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN ER 500 MG TAB has been published 379 times since Apr 3, 2019, and over the history we have for it it has declined 52.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9182 per EA |
|---|---|
| All-time high | $6.1881 (Oct 13, 2021) |
| All-time low | $1.8978 (Aug 19, 2026) |
| 52-week high | $3.6782 |
| 52-week low | $1.8978 |
| Median price | $3.7368 |
| Average price | $3.8571 |
| Largest weekly change | -39.8% (Oct 20, 2021) |
| Weeks tracked | 379 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clarithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN ER 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN ER 500 MG TAB, manufactured by Lannett Company Inc., is $1.9182 per EA (NDC 00527193006), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN ER 500 MG TAB changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN ER 500 MG TAB has declined 52.2%. It has been tracked across 379 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN ER 500 MG TAB?
Since Apr 3, 2019, the NADAC for CLARITHROMYCIN ER 500 MG TAB has ranged from a low of $1.8978 (Aug 19, 2026) to a high of $6.1881 (Oct 13, 2021), with a median of $3.7368 per EA.
Are there cheaper alternatives to CLARITHROMYCIN ER 500 MG TAB?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLARITHROMYCIN 500 MG TABLET, is $0.4658 per EA — about 76% below CLARITHROMYCIN ER 500 MG TAB.
Who manufactures CLARITHROMYCIN ER 500 MG TAB?
CLARITHROMYCIN ER 500 MG TAB (NDC 00527193006) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.